Despite uncertainties regarding regulations on social media usage by pharma, many of the big players are still getting into the game.

A recent Pharma Marketing Blog post online drugs without prescription shares some interesting details on Pfizer’s entrance into social media via Facebook. But according to the post, that entrance wasn’t quite graceful:

When I became a Pfizer FB Pfan, Pfizer’s Wall contained a bunch of short “medicine Safety” videos in which patients talked about their medical conditions and medications. I don’t think any mentioned specific products by name.

When it comes to hospitals engaging with patients and their families on the social web, too many are concerned with justifying the efforts. But a recent blog post from Ragan Communications suggests that’s the wrong strategy completely:

How do hospitals measure their social media ROI? Are they simply tilting at windmills like Don Quixote? Too often, we find ourselves counting the number of Facebook fans or Twitter followers or the number of people who viewed You Tube videos, trying to justify engagement in social media.

However, the bigger question is whether hospitals can afford not to buy prescription drugs without prescription engage.